SATB2 and colorectal carcinoma: Conversely, the expression of the mesenchymal markers Vimentin and MMP-9 were decreased in SATB2-overexpressing CRC cells and their decreases could be partly rescued by SATB2-AS1 silencing (Fig. 4d).